The store will not work correctly when cookies are disabled.
6-Fluoro-3-((E)-2-pyridin-4-yl-vinyl)-1H-indole
ID: ALA435072
Cas Number: 163239-23-4
PubChem CID: 10331757
Max Phase: Preclinical
Molecular Formula: C15H11FN2
Molecular Weight: 238.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Fc1ccc2c(/C=C/c3ccncc3)c[nH]c2c1
Standard InChI: InChI=1S/C15H11FN2/c16-13-3-4-14-12(10-18-15(14)9-13)2-1-11-5-7-17-8-6-11/h1-10,18H/b2-1+
Standard InChI Key: UJTBWNKRXRHIGU-OWOJBTEDSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
0.4917 -2.4375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2958 -2.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4917 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2958 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9875 -1.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7500 -0.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0083 -2.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0083 -0.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5542 -0.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3167 2.2208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7208 -2.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7208 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8125 0.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4375 -2.5875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 2.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8792 1.6083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2625 1.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6250 0.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 5 2 0
4 2 1 0
5 1 1 0
6 3 1 0
7 2 2 0
8 4 2 0
9 6 2 0
10 16 2 0
11 7 1 0
12 11 2 0
13 9 1 0
14 11 1 0
15 17 2 0
16 18 1 0
17 13 1 0
18 13 2 0
3 4 1 0
8 12 1 0
15 10 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 238.26 | Molecular Weight (Monoisotopic): 238.0906 | AlogP: 3.87 | #Rotatable Bonds: 2 |
Polar Surface Area: 28.68 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.28 | CX LogP: 3.34 | CX LogD: 3.33 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.72 | Np Likeness Score: -0.63 |
References
1. Madge D, Hazelwood R, Iyer R, Jones H, Salter M. (1996) Novel tryptophan dioxygenase inhibitors and combined tryptophan dioxygenase/5-HT reuptake inhibitors, 6 (7): [10.1016/0960-894X(96)00124-2] |
2. Dolusić E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R.. (2011) Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators., 54 (15): [PMID:21726069] [10.1021/jm2006782] |